This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

What Do We and Don't We Know?

Len Scarpinato, DO

Arch Intern Med. 1997;157(22):2543-2544.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE WHOLE SUBJECT of human immunodeficiency virus (HIV) infection and pregnancy has alternately been a hotbed of discussion for those clinicians involved with HIV or ignored by the clinicians not involved. We are now only beginning to understand how HIV affects pregnancy.

How HIV affects pregnancy has been most dramatically revealed in the studies addressing transmission of HIV during pregnancy. This is not the purpose of this editorial as it has been dealt with elsewhere. However, 2 other things are clearly known: (1) there is a high fetal loss among HIV-positive mothers¹; and (2) zidovudine (AZT) should be used during pregnancy to reduce the incidence of transmission.² We now know maternal vitamin A deficiency contributes to the mother-child transmission of HIV. Nutritional augmentation of vitamin A in pregnant women with HIV probably makes sense.³

One of the ways a patient can become HIV positive is through substance . . . [Full Text PDF of this Article]

Author Affiliations
Racine Family Practice Residency PO Box 548 Racine, WI53401

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?